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Abstract The objective of this study was to ascertain the
long-term safety of loading osseointegrated implants for
bone conduction hearing 3 weeks post-surgery. Thirty
consecutive adult patients were implanted with the Baha
BI300 (Cochlear Bone Anchored Solutions) in our tertiary
referral center. Implants were loaded with the sound pro-
cessor 3 weeks post-surgery. Follow-up examinations were
performed at 10 days; 3, 4, 6, 8, and 12 weeks; 6 months;
and 1, 2, and 3 years after implant surgery. At each follow-
up visit, implant stability quotient (ISQ) values were
recorded by means of resonance frequency analysis, and
soft tissue status was evaluated according to Holgers’
classification. ISQ trends, implant survival, and soft tissue
reactions were compared to a population of 52 patients
with the same type of implants loaded from 6 weeks post-
surgery as part of another study. Subjective benefit was
measured by means of the Glasgow Benefit Inventory
(GBI). After an initial dip in ISQ at 10 days after
implantation, a gradually increasing trend in ISQ was
found until 6 months in both populations, after which ISQ
values remained above baseline values. Implant survival
was 97 % in the study population and 96 % in the com-
parison population. Clinically relevant soft tissue reactions
were found in 0.9 % (study population) and 1.7 % (com-
parison population) of all visits. Patients reported
subjective benefit; the mean GBI score was 22.8. In con-
clusion, loading these implants at 3 weeks post-surgery is
safe based on the current study, as long-term results show
high ISQ values and good implant survival and tolerability.
Keywords Bone-anchored hearing aid  Baha  Early
loading  ISQ  Skin reaction  Hearing loss
Introduction
Percutaneous osseointegrated titanium implants in the
temporal bone have been used since 1977 to attach a
vibrating sound processor to accomplish hearing amplifi-
cation for several indications [1, 2]. Obviously, an implant
needs to be sufficiently fixated to the bone before loading it
with the sound processor is feasible. In the earliest days,
implant surgery consisted of two stages, allowing a mini-
mum of 3 months of osseointegration time before the
percutaneous abutment was connected to the implant,
which allowed loading with the sound processor [1, 3].
Later on, clinical application of a one-stage surgical tech-
nique was reported with a healing time of 6–8 weeks before
loading the implant [4].
To allow patients to start using their device as soon as
possible, yet safely, after implantation, loading times have
gradually decreased. This was mostly stimulated by dental
research where earlier (and even immediate) loading pro-
tocols are common practice. A recent Cochrane review [5]
concluded that there was no convincing evidence of a
clinically important difference in prosthesis failure,
implant failure, or bone loss associated with different
loading times of dental implants. However, the quality of
the evidence was assessed as very low due to risks of bias
in primary studies and some evidence of reporting bias.
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Furthermore, dental implants are different from implants
for bone conduction hearing. Therefore, clinicians are
advised to treat these findings with caution.
In 2005, a loading time of 4–6 weeks after implantation
was advised based on expert opinion [2]. Subsequently,
even earlier loading protocols have been reported [6, 7].
These results were all found using 3.75-mm-diameter
implants. In 2010, a 4.5-mm-diameter implant with a
moderately roughened surface was introduced. The larger
implant diameter increases the bone–implant contact sur-
face, which should theoretically result in a larger area for
osseointegration, while the moderately roughened surface
is thought to stimulate the initial healing response of the
bone directly after implantation. Promising short-term
clinical results of applying a loading time of 6 weeks after
implantation with this implant were reported [8]. Subse-
quently, even shorter loading times of 4 [9], 3 [10], and 2
weeks [11] were advocated when using this implant.
The current study is a continuation of the study that
presented the clinical results of loading at 3 weeks with a
follow-up period of 6 months [10]. Study outcomes con-
cern the clinical results on implant stability quotient (ISQ),
implant survival, and soft tissue tolerability of this wide
and moderately roughened implant loaded at 3 weeks with
a follow-up period of 3 years. This is considerably longer
than all other early loading data published to date, which
have been presented with a follow-up of 1 year or less.
Additionally, outcomes were compared to those from
another study of the same type of implant, which, however,
had been loaded from 6 weeks with a 3-year follow-up
period [12]. Furthermore, subjective benefit of the bone
conduction hearing system was measured [13].
Materials and methods
Ethical considerations
The current study was conducted in accordance with the
guidelines established in the Declaration of Helsinki and
the ISO 14155:2011 Clinical investigation of medical
devices for human subjects—Good clinical practice, and
was approved by the local ethics committee.
Patients and implants
Thirty consecutive patients (referred to as the ‘‘study
population’’) were included in this prospective cohort study
to have their Cochlear Baha BI300 4-mm implant with a
BA300 6-mm abutment (Cochlear Bone Anchored Solu-
tions AB, Mo¨lnlycke, Sweden) loaded with the sound
processor at 3 weeks after surgery.
Since at the conception of the current study neither
clinical outcomes with the study implant nor implant
loading at 3 weeks had been reported, only adult patients
with normal bone quality were considered for participation
in the study. To be included in the study, subjects had to
meet each of the following inclusion criteria: be 18 years
of age or older; be eligible for implantation and for the
sound processor; and must provide written informed con-
sent to participate in the study. Exclusion criteria were:
being unable to follow the investigational procedures;
simultaneous participation in another investigation with
pharmaceuticals and/or devices; disease and/or treatment
that compromises/will compromise the bone quality at the
implant site, such as radiation therapy and osteoporosis
(assessed by medical history); psychosocial problems or
psychiatric disease; and, finally, the inability to attend all
scheduled follow-up visits. Furthermore, if patients were
assessed during implantation to have a bone thickness at
the implant site of less than 4 mm, they were excluded. All
subjects were free to discontinue participation in the
investigation at any time without giving a reason and
without prejudice regarding further treatment.
The results from the current investigation were com-
pared to those of 52 patients (referred to as the ‘‘compar-
ison population’’), implanted with the same type of implant
and abutment, reported on in a previous multicenter study
with similar inclusion and exclusion criteria and an almost
identical study protocol, however, with implant loading
from 6 weeks after surgery. Thus, this population is not a
formal control group. Therefore, methods and outcomes
concerning this group will not be described in detail in the
current manuscript. For more details on methods and
results concerning the comparison population, please refer
to the original study [8, 12].
Study design
The primary objective of the current study was to evaluate
the long-term stability of the implant placed in one-stage
surgery and loaded after 21 days of healing. Secondary
objectives were to evaluate the long-term survival of the
implant, demonstrate the safety of the implant as assessed
by the occurrence of adverse soft tissue reactions, evaluate
changes in quality of life post-implantation, and, finally,
evaluate hearing loss-associated disability and the reduc-
tion of disability achieved with the device. The outcomes
for the study population in the present prospective inves-
tigation were compared to those of the comparison popu-
lation for all study parameters that were equivalent
between studies.
No sample size calculation was conducted, as no dif-
ferences between groups were expected. Thus, the study
population size was chosen empirically.
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After inclusion and having provided written informed
consent, patients in the current investigation underwent
one-stage implant surgery with subcutaneous tissue
reduction, according to the Nijmegen linear incision tech-
nique [14], in June and July 2010. Surgery was performed
by two experienced implant surgeons (E.M. and M.H.).
Follow-up examinations were performed at 10 days; 3, 4,
6, 8, and 12 weeks; 6 months; and 1, 2, and 3 years after
implant surgery.
During all follow-up visits, the implant stability quotient
(ISQ) was measured by means of resonance frequency
analysis (RFA) with the Osstell Mentor (Osstell AB,
Go¨teborg, Sweden), an objective and non-invasive tech-
nique. RFA provides information about the stiffness of the
implant–bone junction [15] and produces two ISQ values:
ISQ High and ISQ Low, usually obtained from perpen-
dicular measurements and generally differing a few points.
Both values may be used for interpretation; however, as
trends should be analyzed, it is important to use one of both
values consistently. In the current study, the ISQ High
values were used in the statistical analyses. In cases where
an abutment was replaced by a longer one during follow-
up, ISQ values were no longer included in the analysis
from that point on, as a change in the length of the abut-
ment affects the ISQ values. Soft tissue status was moni-
tored and graded according to Holgers’ classification [16].
Implant loading occurred at 3 weeks, provided that the
stability of the implant (evaluated clinically and not based
on an absolute ISQ value) and soft tissue status were
judged to be satisfactory. Significant postoperative wound
healing complications or a soft tissue reaction corre-
sponding to a Holgers grade 3 or higher would result in
postponed implant loading.
To measure subjective benefit in a standardized and
comparable manner, the study population was asked to fill
out the Glasgow Benefit Inventory (GBI) at 3 months and
at 3 years. The GBI measures the change in health status
effected by otorhinolaryngological surgical interventions
[13]. Three subsections comprise 18 items: 12 relating to
general improvement, 3 to social improvement, and 3 to
physical improvement. Each question was answered on a
five-point Likert scale. The GBI was not included in the
study protocol of the comparison population’s original
study that had already started more than a year earlier;
hence, comparison between studies in terms of subjective
benefit was not possible.
Statistical analysis
All study data were directly entered into an SPSS data file
from the patients’ medical records by the investigators.
After anonymization, the data were analyzed by indepen-
dent biostatisticians (Statistiska Konsultgruppen, Go¨teborg,
Sweden). The statistical analyses were performed accord-
ing to a pre-defined statistical analysis plan. A correction
factor was developed and validated in the reference
material by Osstell AB to transfer the ISQ values measured
in the present study to corrected ISQ values to address the
use of different SmartPegs, as a change in SmartPeg type
was advised during the course of the study. Only these
corrected ISQ values (i.e., comparable to measurements
with SmartPeg type 55) are presented throughout the study
to make it possible to compare ISQ values between the
present study and the comparison population. A weighted
average of ISQ values during the period between baseline
(time of implantation) and the 3-year follow-up was
obtained by determining the mean area under the curve
(AUC) using the trapezoid rule. The mean AUC was cal-
culated for the time the implant was functional. For
patients who were lost to follow-up, the last observation
carried forward was used in the mean AUC calculations.
Comparisons between the study and comparison popula-
tions were made using Fisher’s exact test for gender, the
Mann–Whitney U test for age and ISQ values, and the
Mantel–Haenszel Chi-square test for the comparison of
Holgers’ grades. A significance level of 95 % was adopted.
Results
Patients
A total of 31 patients were approached for participation.
One patient declined participation due to logistical rea-
sons that prohibited being available for all follow-up
visits. Table 1 displays the characteristics of the 30
consecutive patients included in the study population.
The characteristics of the 52 patients from a previous
investigation [12], who served as the comparison popu-
lation, are displayed in the same table and are found to
be comparable. In both groups, three patients were
excluded during follow-up. The reasons for exclusion
from the current study were: implant loss (after 3 days),
non-implant-related death (after 22 months), and lack of
follow-up (patient left out of analyses; missed four out
of eight scheduled visits).
Implant loading
Due to the implant loss that occurred before loading in one
patient, 29 implants were loaded. The mean loading time in
the study population was 3.2 weeks. Loading occurred in
28 patients within the 3-week visit window (mean
22 days). In one patient, loading was postponed to 36 days
post-implantation because of incomplete soft tissue healing
at 3 weeks post-implantation. At the 3-week follow-up,
Eur Arch Otorhinolaryngol (2016) 273:1731–1737 1733
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ISQ High values ranged between 64 and 73. The mean
loading time in the comparison population was 8.3 weeks.
Implant stability quotient
The mean AUC for ISQ High over 3 years was 68.5 (SD
5.0) for the study population. Figure 1 displays the mean
ISQ High values at each follow-up visit. After an initial dip
in mean ISQ 10 days after implantation, ISQ gradually
increased until 6 months after implantation. A dip in ISQ
was found at 2 years, after which mean ISQ increased at 3
years to the same mean value as found at 1 year. From 2
years and onward, the spread in ISQ values increases (as
seen by an increase in 95 % confidence intervals of mean
ISQ). Two patients required an abutment replacement to a
longer 9-mm abutment, due to soft tissue problems with the
shorter 6-mm abutment. Their ISQ data were not analyzed
from that point on, as different abutment lengths affect the
ISQ. The trend of ISQ values as a change from baseline is
similar to that observed in the comparison population, as
represented by Fig. 2.
Implant survival
Implant survival was 97 %. The sole implant loss occurred
3 days after surgery in a 65-year-old male with single-sided
sensorineural deafness who had no history of diabetes or
smoking. The measured ISQ at the time of implantation
was 44. In the comparison population, a single implant was
lost and another implant was electively removed, resulting
in 96 % survival.
Soft tissue tolerability
Figure 3 provides an overview of soft tissue reactions per
visit. Mean local soft tissue status according to Holgers for
all visits throughout the entire follow-up period were
recorded: Holgers grade 0 in 88.5 %, Holgers grade 1 in
10.6 %, Holgers grade 2 in 0.9 %. No Holgers grade 3 or 4
soft tissue reactions were recorded. Similarly in the com-
parison population, only Holgers grade 0 (79.9 %), 1
(18.3 %), and 2 (1.7 %) were recorded. The maximum
severity of soft tissue reactions throughout all visits for
Table 1 Patient characteristics
for the study population (3-
week loading) and the
comparison population (6-week
loading)
3-week loading (n = 30) 6-week loading (n = 52) p
Gender, n (%)
Male 14 (46.7) 23 (44.2) 1.00
Female 16 (53.3) 29 (55.8)
Age (years), mean (SD) 55.3 (12.3) 55.5 (13.8) 0.92
Indication for implant
CMHL 19 (63.3) 34 (65.4)
SSD 10 (33.3) 17 (32.7)
Other 1 (3.3) 1. (1.9)
CMHL conductive or mixed hearing loss, SSD single-sided sensorineural deafness
Fig. 1 Box and whisker plot of ISQ High values for the study
population (3-week loading). Mean (cross) and median (horizontal
line) are defined within the box plot. Dots represent outlier values
Fig. 2 Change in ISQ High from baseline for the study population
(3-week loading) and the comparison population (6-week loading)
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each patient showed no statistically significant difference
(p = 0.22) between the study and comparison populations.
Within the comparison population, the percentages of
Holgers grade 2 soft tissue reactions were comparable
between the different centers, each of which applied their
customary soft tissue handling technique [12].
Subjective benefit
The response rate of patients who returned a completed
GBI questionnaire at the 3-year follow-up was 88.9 %
(n = 24). Of these responders, 18 used the sound processor
daily, 4 sporadically, 2 stopped, and 2 had lost their sound
processors. The daily users reported a mean GBI total score
of 22.8, compared to 11.1 reported by the sporadic users
and -20.8 by the non-users.
Discussion
The time between surgery and the point at which implants
are loaded with the sound processor has gradually
decreased over the years with the aim of enabling patients
to benefit from their hearing device as quickly as possible.
However, early loading should be safe and, thus, should not
compromise implant stability and wound healing. The
current study investigated the long-term safety of reducing
the loading time to 3 weeks after implantation and provides
a comparison to previously reported data on loading from 6
weeks [12]. In terms of ISQ values, implant survival and
soft tissue tolerability, no significant differences were
found between the two populations.
The major strength of the current study was its
prospective design. Therefore, the current study data are
considered to provide a substantial amount of information
on the long-term safety of this early loading protocol.
There is a limitation in the comparison with a group loaded
from 6 weeks from another prospective multicenter study
[8, 12], in that this comparison was not set up as a ran-
domized controlled prospective trial. Furthermore, 24
(46.2 %) of the implants of the comparison population
were placed using different soft tissue reduction tech-
niques, due to the multicenter design of that original study;
the use of different soft tissue reduction techniques could
have led to potentially different soft tissue outcomes
between the two studies (although in the multicenter study,
the outcomes were shown to be comparable between sites
using different techniques), but are not expected to have a
significant effect on the implant stability, which was the
primary analysis of the current and the former study. The
inclusion and exclusion criteria of both studies were
similar.
ISQ trends over time were not found to be influenced by
loading the implant at 3 weeks compared to loading from 6
weeks. An initial dip in ISQ during the first follow-up
examination after implantation was found, which is
believed to be attributed to normal bone remodeling
characteristics [10]. No decrease in ISQ values during the
immediate period after implant loading at 3 weeks was
observed. This suggests that the level of stability at 3
weeks after implantation of the current implant is adequate
to support the sound processor. As with the comparison
population, ISQ values remained above baseline values, as
measured at implantation, from the time of loading until
follow-up had been conducted for 3 years. Interestingly, in
the study population there is a dip in mean ISQ after 2
years of follow-up, after which mean ISQ increases again
at 3 years. We have no explanation for this one-point dip,
but it is not deemed to be of clinical significance, as it did
not result in implant loss and the ISQ values increased
again at 3 years. It might be interesting to follow these
implants even longer. The increase in 95 % confidence
intervals of mean ISQ after 2 years is also observed in the
comparison population. Furthermore, the comparison
population shows a decreasing trend in ISQ at 3 years. We
do not have an explanation for this decreasing trend,
although a possible explanation could be marginal bone
loss around the implant, a phenomenon known to occur in
dental implantology [17]. However, in that case we do not
understand why there is a difference between the trends for
these two groups.
Despite slightly decreasing ISQ trends during some
periods, implants remained clinically stable and without
any peri-implant problems. The mean AUC of ISQ was
slightly lower in the study population (68.5, SD 5.0)
compared to the comparison population (71.5, SD 2.2). It is
unclear whether this difference is clinically relevant. In the
sole implant that was lost in the study population, a
remarkably low ISQ value of 44 was measured at
Fig. 3 Soft tissue reactions as a percentage of visits according to
Holgers’ classification for the study population (3-week loading) and
the comparison population (6-week loading)
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implantation. Looking at the data of the current study and
other studies using implants and abutment of the same type
and size [9, 11, 12], ISQ in this type of implant rarely drops
below a value of 55. However, it is not currently possible to
determine strict ISQ values that indicate the point at which
loading is safe; only ISQ trends over time should be
interpreted for clinical use. More ISQ data will be needed
to establish the clinical relevance of specific values. Dental
implantological studies have shown that high ISQ values
are indicative of a successful implant treatment with a
small risk of future failure, while low or decreasing ISQ
values point to an increased risk of implant complications
[15].
Implant survival was high in both the study (97 %) and
comparison populations (96 %) at 3 years post-surgery,
although neither of the studies was powered to demonstrate
significant differences in implant survival. These fig-
ures compare positively to those reported on the previous
3.75-mm-wide as-machined titanium implants in a long-
term retrospective study (92 %), which also demonstrated
that implant loss occurred most frequently (79.8 % of all
lost implants in that study) in the first 3 years after
implantation [18]. In dental implantology, wider implant
designs have been reported to increase implant stability
[19] and moderately roughened surfaces have been repor-
ted to increase bone response after implantation [20].
Soft tissue tolerability was comparable between the
study group and the comparison group. This indicates that
earlier loading of the implant does not influence soft tissue
healing negatively nor positively. The percentages of
clinically relevant soft tissue reactions (Holgers grade 2 or
higher) are favorable for both the study and comparison
populations compared to those reported in retrospective
studies [18, 21]. As these retrospective studies predomi-
nantly report on the previous implant with a conically
shaped abutment, the positive soft tissue tolerability
recorded in the current investigation can most likely be
attributed to the new rounded abutment design, possibly in
combination with a more stable implant. This is confirmed
by a previous prospective randomized controlled clinical
comparison of the rounded abutment design and a conically
shaped abutment [12].
To date, few studies have reported long-term clinical
outcomes from prospective studies of the current implant.
However, long-term stability and survival are crucial
parameters for a successful implant. Therefore, in addition
to the need for more long-term data to be published, fol-
low-up periods exceeding 3 years will be of great interest.
Subjective benefit as measured by the GBI in the daily
users group (22.8) was comparable to the score measured at 3
months (20.9). Satisfaction with the implant and device did
not change appreciably over time. As can be expected,
patients who used their sound processors less frequently or
not at all reported lower scores. Because the GBI was only
completed by the study population, a comparison of satis-
faction between both populations to establish whether earlier
loading provides more subjective benefit was not possible.
The currently reported GBI score corresponded to GBI
scores measured in comparable study populations [22, 23].
Conclusion
The reported long-term results of an early loading protocol
at 3 weeks post-implantation indicate good ISQ values over
time, implant survival, and soft tissue tolerability. These
results were compared to those of the same implant type
loaded from 6 weeks post-implantation in a previous
investigation, which revealed no notable differences. Based
on the current results, loading the tested implant is safe in
adult patients with normal bone quality from 3 weeks post-
implantation.
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